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Objective: To explore how caregivers are involved in making treatment decisions
for older people living with dementia and a new diagnosis of cancer.
Method: A systematic review of PubMed, CINAHL, PsycINFO, Web of Science,
and Scopus databases was conducted. Studies recruiting formal or informal caregivers
for older people with dementia and a diagnosis of cancer were considered for
inclusion.
Results: Of 1761 articles screened, 36 full texts were assessed for eligibility, and six
were included in the review. This review has identified that health care professionals
(HCPs) are often unaware of the coexistence or severity of dementia in cancer
patients, and therefore fail to properly address care needs as a result. While care-
givers are relied on to help make decisions, they have unmet information needs and
feel excluded from decision‐making.
Conclusion: Treatment decision making in the context of older adults with demen-
tia and a new diagnosis of cancer needs further research. This will help HCPs to
understand their needs and improve the experience of decision making for both care-
givers and the people that they care for.
KEYWORDS
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Over the past 25 years, there has been a substantial growth in the older
adult population, who now represent the fastest growing demographic
in the United Kingdom.1 Older adults are now living much longer with
advanced stages of age‐related comorbidities, such as cognitive impair-
ment, and have an increased vulnerability to age‐related disease and
cancers. The global incidence of dementia is approximately 10 million
new cases each year,2 with around 850 000 people diagnosed with- - - - - - - - - - - - - - - - - - - - - - - - - -
Creative Commons Attribution Li
by John Wiley & Sons Ltdsome form of dementia in the United Kingdom.3 The demographic out-
look suggests that by 2021 an estimated 1 000 000 people will be living
with some form of dementia. Advancing age is also a significant risk fac-
tor for cancer, with over half of all cancers being diagnosed in the over
70 age group each year in the United Kingdom.4
Dementia is a disease characterized by a progressive set of condi-
tions that include loss of judgment, reasoning ability, and memory; all
of which will impair capacity to make informed decisions.5 The scope
of dementia impacts so much more than just memory; it can impair- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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1198 MARTIN ET AL.language, perception, and the ability to undertake daily tasks without
additional care and assistance. Together, these changes over time can
place a profound burden on their family and caregivers, especially in
the later stages of dementia, which will increase the need for care ser-
vices, psychosocial support, and assistance with treatment decision
making.6 Dementia severity and the trajectory of functional decline
vary from person‐to‐person, meaning that older adults who live with
this condition are highly heterogeneous. Some people with memory
problems may be living without a formal diagnosis or may avoid visiting
their GP through fear and stigma of the disease.7 While some older
adults in the early stages of the disease may have mild impairment
and can still make informed decisions, others in the severe or later
stages of dementia will rely on the input of others, such as their family
and caregivers.8
Caregivers can either be formally or informally appointed to help
make decisions on behalf of a person who lacks the capacity to make
their own decisions.9 Some caregivers may be legally appointed to this
role while the individual still has capacity, while others may take on
this role suddenly or gradually over time. Under current U.K. law, care-
givers must have lasting power of attorney (LPA) for health and wel-
fare in order to make treatment‐related decisions on behalf of
another person. The role of the caregiver in this scenario is to elicit
the preferences of the person living with dementia and navigate,
which treatments are in their best interests.10 In the literature, this is
often referred to as proxy or surrogate decision making.
As the aging process varies, some older adults may be considered fit-
ter than others and able to withstand different levels of treatment.
Treatments for new cancer diagnoses should therefore be tailored and
take into account any existing comorbidities and treatment regimes.6
For older adults with normal cognition, following routine clinical investi-
gations and diagnosis, there will be a discussion about the pros and cons
of treatment options together with the treating clinician before making
an informed decision. Family, caregivers, and friends may be involved
in the consultation and offer their support, but ultimately, the patient
will make this decision and give their consent to treatment.
For people living with dementia, the process of diagnosis may differ
significantly to thosewith no cognitive impairment; screening opportuni-
ties may be limited, and undergoing diagnostic investigations may pres-
ent a burden to the person living with dementia and their caregiver.11
Clinical investigations such as scans and biopsies may also be more chal-
lenging. People with dementia may also lack the capacity to understand
the treatment options available, and informationmay need to be adapted
or presented in a manner adapted to their cognitive capacity. The lan-
guage deficits frequently associated with severe dementia may mean
that some people living with the disease are not able to communicate
their decision and give verbal consent to treatment. Caregiver involve-
ment may therefore be needed to interpret the patient's wishes and help
guide the consultant towards a treatment plan that takes into account
the wishes of the patient and is in their best interests.
In the United Kingdom, there are ethical frameworks that guide
treatment decision making for both caregivers and clinicians,12 and
there are legal guidelines that help individuals state their treatment
preferences while they still have capacity to do so.13 The conceptsof autonomy and informed decision making are paramount and should
be upheld in cases where treatment preferences have been stated in
an advance directive (AD) before the person lost capacity.14 An AD
designates instructions for future medical treatment or for a decision
maker with LPA to act on their behalf. Advance decisions are useful
because they allow people to retain autonomy over their future treat-
ment, particularly in cases where there is no opportunity to have a dis-
cussion about treatments. The reality is that not all people are able to
state their preferences in advance of losing capacity and may not
always have an AD in place.15 As a result of these issues, caregivers
and clinicians may be presented with ambiguous circumstances where
the preferences of the person they care for are unknown or have not
been previously stated. In cases where it is not possible to determine
which treatments the patient might decide for himself or herself, the
principle of best interests should be used, and a best interest meeting
may be held; involving clinicians, caregivers, individuals with LPA and
sometimes even the person with dementia themselves.
Little is currently known about how caregivers are involved in mak-
ing cancer treatment decisions for the older, cognitively impaired pop-
ulation. Previous reviews have struggled to identify many studies that
have directly explored the experiences of people with dementia and
their caregivers in this context.16 A recent review by Hopkinson and
colleagues, which sought to find out about the experiences of people
with cancer and dementia, found that people with dementia were
more likely to have a delayed diagnosis and receive fewer treatments
compared with cancer patient who did not have dementia.17
The aim of this review was to address a gap in knowledge by
exploring how caregivers are involved in making cancer treatment
decisions for older people with dementia who receive a new diagnosis
of cancer.2 | METHODS
2.1 | Search question
How are caregivers involved in making treatment decisions for older
people with dementia and a new diagnosis of cancer?2.2 | Search strategy
A comprehensive search of the literature was conducted in accor-
dance with PRISMA guidelines18 between June and September 2018
and revised again in January 2019. The following databases were
searched: CINAHL, PubMed (via MEDLINE), PsycINFO, Scopus, and
Web of Science. Hand‐searching reference lists and the gray literature
also obtained references. The search was limited to the English lan-
guage. Given the nature of the research question, an adapted “PCO”
framework19 was used for this review. A broad range of key search
terms and MeSH topics were used based around the topics of “deci-
sion making,” “caregivers,” “dementia,” and “cancer.” A combination
of free text searches and MeSH terms were used to identify articles.
MARTIN ET AL. 1199An example of the search strategy for PubMed (via MEDLINE) is
shown in Data S1.2.3 | Eligibility criteria
The search aimed to identify qualitative, quantitative, or mixed
method studies that recruited caregivers (both informal and formal)
for people living with dementia. Studies were included if they made
reference to cancer treatment decision making for older people living
with dementia. This included studies that observed treatment discus-
sions in consultations and caregiver perspectives on hypothetical
treatment scenarios. Reviews, letters, case studies, editorials, and con-
ference abstracts were excluded. Studies were limited to those that
focused on older adults (>60), as this age is widely accepted as a lower
cut‐off for chronological older age.202.4 | Quality appraisal
Two reviewers (C.M. and A.S.) discussed and selected the articles
included in this review. The rationale for including studies with
either a mixed method, qualitative, or quantitative design was thatFIGURE 1 PRISMA flow diagramthis would allow a broad understanding of the research topic. Search
results were imported to endnote for screening and full text
retrieval. Studies were selected for this review using a two‐step pro-
cess; articles were first screened by title and abstract to determine
relevance to the review. The PRISMA search strategy18 was used
to filter articles and remove any duplicates (Figure 1). Full text arti-
cles were then retrieved to assess relevance against the inclusion
criteria and then independently reviewed.
The Mixed Method Appraisal Tool (MMAT)21,22 quality checklist
was used to appraise each study. The MMAT criteria include two
screening questions and 19 items to appraise five types of study (qual-
itative, quantitative randomized controlled trials, quantitative
nonrandomized, quantitative descriptive, and mixed methods). Quality
assessment scores were calculated for each study using the MMAT
score, ranging from one criteria met (25%) to all criteria met (100%).
No study was excluded on the basis of quality assessment as the
authors chose to include studies that represented the small amount
of literature exploring decision making for people with dementia and
cancer. However, for qualitative studies, the question “(1.4). Is appro-
priate consideration given to how findings relate to researchers' influ-
ence, e.g. through their interactions with participants?” was unclear or
not always addressed.
1200 MARTIN ET AL.2.5 | Analysis
Thematic analysis was undertaken in accordance with the Framework
approach.23,24 This process involved coding the key findings across
studies and then developing themes, which were then summarized
within a framework matrix. Reviewing the matrix generated the final
themes. The analysis was guided by an interpretivist approach.3 | RESULTS
The search produced a total of 1935 results. Of these, 174 duplicates
were removed, and 1725 were excluded, as they did not meet the
inclusion criteria. The remaining 36 articles were retrieved for full text
review, and six of these were deemed suitable for inclusion. The term
“caregiver” has been used throughout this paper to represent carers
and informal caregivers. Health care provider (HCP) has been used
as a comprehensive term for the treating clinician, consultant or oncol-
ogy staff.3.1 | Study characteristics
Of the six studies included (Table 1), five were conducted in the
United Kingdom and one in the United States. One study used a quan-
titative cross sectional design,25 and five studies used a qualitative
design.26-30 Two studies explored treatment decision making in the
context of hypothetical treatment scenarios,25,26 three studies
observed prospective treatment decision making in clinical scenar-
ios,27-29 and one study interviewed patients and caregivers who were
reflecting retrospectively on the cancer diagnosis and treatment deci-
sion making.30
All six studies used semi‐structured interviews (face‐to‐face or
telephone) with informal/familial caregivers to collect primary
data. Five qualitative studies used a framework, thematic, or
narrative analysis,26-30 and one study used descriptive statistics.25
Two studies observed or interviewed HCPs in addition to care-
givers,27,28 and four studies also included the views of people with
dementia.25,27,28,30
Four studies specified a clinical diagnosis of dementia for the
patient being cared for in their inclusion criteria,25,28-30 and one study
included caregivers for patients with a memory problem, as judged by
the HCP and patient.27 Five studies recruited participants from either
cancer clinics27-30 or memory clinics,25 and one study recruited care-
givers from a dementia registry.26
Three studies reported their sampling method as purposive,28-30
while others were unclear.25-27 The sample sizes of interviewees
reported in the qualitative studies ranged from six to 60 patient‐
caregiver dyads,25,27,30 and seven to 23 caregivers interviewed indi-
vidually.26,28,29 Two studies interviewed patients with dementia indi-
vidually in their case sample.28,30
Thematic analysis using established theorists such as Wolcott
framework and Braun and Clarke thematic analysis were used in three
qualitative studies,27,28,30 and Riessman narrative approach was usedin one study.29 One study measured responses using caregiver specific
questionnaires, such as the Quality of Carer Patient Relationship ques-
tionnaire (QCPR).25
3.2 | Findings
Because of the study design of selected papers, a meta‐analysis was
not possible. Data have been categorized into three themes that
interplay with the caregiver experience of making treatment decisions:
(a) HCP dementia awareness and knowledge in the clinical consulta-
tion; (b) treatment decision‐making discussions, information, and com-
munication needs; (c) the caregiver role and the caregiver‐patient
relationship.
3.2.1 | HCP dementia awareness and knowledge in
the clinical consultation
Following screening, clinical investigation, and diagnosis, the initial
cancer consultation was often the first point in the cancer treatment
pathway where HCPs met with patients and their caregivers to discuss
treatment options. Four studies explored the experiences of care-
givers and HCPs in the cancer setting through observation of consul-
tations27 and semi‐structured interviews.27-29 Caregivers in one
study reflected back on the consultation where the person living with
dementia received their cancer diagnosis.30
Having access to detailed patient information, such as past medical
history, comorbidities, and cognition level enabled HCP's to plan suffi-
cient time for discussion in the consultation.28 McWilliams and col-
leagues noted that cognition status was not always known to the
HCP in advance of the consultation,28 and dementia was also infre-
quently documented in the patient's referral information or medical
records in the study led by Courtier and colleagues.27 In both studies,
the identification of memory problems was often reliant on caregiver
disclosures.27,28 As a result of this unawareness, one caregiver
described a scenario where the HCP failed to acknowledge his wife's
distress when undergoing a clinical investigation, alongside failing to
fully explain what the procedure entailed and what was expected.30
In most studies, the caregiver accompanied the patient in the
consultation where treatment options were discussed. In the study
led by Witham and colleagues, one caregiver described a series of
scenarios that led to missed appointments where the patient
attended their appointment unassisted; this was due to unclear sign-
age in the clinic and an absence of staff to guide the patient once in
the hospital.29 The cognitively impaired patient also had a coexisting
hearing problem and was unable to hear his name being called.
Another caregiver in this study highlighted the logistics of
transporting people with dementia who live on their own in the
community to their appointments. A scenario was recalled where
the patient's erratic sleep pattern was incompatible with the
arranged transport pick‐up time. This meant that without prompts,
the patient would miss their transport to the appointment.29
In the context of consultation discussions, caregivers felt that
decisions had been made by HCP's prior to the initial consultation28
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1202 MARTIN ET AL.and relayed feeling excluded from decisions.29 Caregivers in
McWilliams and colleagues' study highlighted the uncertainties
around taking consent from people with dementia to undergo clinical
investigations and the level of responsibility expected from care-
givers.30 Caregivers also highlighted the need for additional appoint-
ments, where treatment plans could be discussed further,
independently from the patient.29
Caregivers in the study led by Courtier and colleagues noted that
the cancer consultation had a tendency to focus primarily on cancer
treatments, rather than cognition‐related problems.27 This subse-
quently led to memory problems remaining undiscovered. In two stud-
ies, it was noted that patients would often underplay memory
problems27 and dispute their inability to cope with treatment as a
result of their impairment.29 Cancer diagnostic investigations were
often delayed due to the combination of limited HCP awareness of
memory problems and a failure to detect the signs associated with
dementia.28 The lack of timely organization of support for people with
memory problems was therefore an issue.27,28
Two studies highlighted that dementia awareness training for can-
cer clinicians was needed.27,28 The reasons for this included a lack of
awareness of the impact that dementia may have on cancer screen-
ing28 and the potential for interaction between the patients' dementia
symptoms and cancer treatment.27 Being unaware of the patients'
ability to give informed consent may result in HCPs taking the refusal
of treatment at “face value,” as noted by a caregiver in the study by
Witham et al.29 Witham and colleagues describe one situation where
a patient failed to complete their radiotherapy treatment due to refus-
ing to attend appointments. This scenario was a result of the HCP fail-
ing to acknowledge that the person with dementia lacked the capacity
to make informed decisions. In examples where HCPs were made
aware of cognition problems in the patient, there was an uncertainty
on how to best support them.27
In Smyth's26 study of breast screening and treatment prefer-
ences, caregiver decisions were found to be influenced by HCPs in
regards to continued breast imaging; with a tendency to continue
screening based on the clinician's recommendations. Witham and
colleagues also noted the dominance of the HCPs' knowledge in
the consultation, through a scenario where a caregiver relayed feel-
ing that their judgment of the patient's progress and response to
treatment was challenged.29
The need to involve dementia‐specific support at the outset was
emphasized by caregivers, with one study highlighting the example
of a designated dementia nurse and biographical tool, which was
used in clinic to enhance support for patients with dementia.27
Two studies highlighted the need for HCP familiarity and how this
was accomplished by using a designated HCP to coordinate
care.28,29 This avoided the need for repetitive recall of the patients'
medical history and unnecessary frustration and anxiety for the
patient.29 McWilliams and colleagues reported a positive scenario
where the caregiver found it helpful to have the HCP repeat the
information to her husband and pay more attention to the pacing
of the consultation, which led to a positive experience for both the
caregiver and the person with dementia.30
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information, and communication needs
Weighing up the pros and cons of treatment options for a person liv-
ing with dementia may not only involve the caregiver; the HCP and
patients themselves may also be involved in making these decisions.
Five studies reported on the direct influence of dementia on cancer
treatment discussions.26-30
For people with dementia or memory issues, extra time may be
needed to communicate information about their cancer diagnosis
and treatment options. One study highlighted a scenario where a care-
giver relayed his mother's lack of awareness of her diagnosis due to
her dementia and relayed a scenario of conveying the diagnosis to
his mother using a “creative strategy” and metaphors.30 Caregivers in
Witham and colleagues' study also described the need for “complex
communication strategies.”29 Examples of this in other studies
included taking more time to discuss options,30 “slowing down” infor-
mation delivery and using a change in language to communicate com-
plex treatment information.28
In situations where patients lacked capacity, the caregiver gath-
ered treatment information and negotiated on behalf of the
patient,27,29 acting “as a reliable messenger” or “relayer of information”
between the HCP and the patient.28,30 In another study, one caregiver
reflected on this role in assisting the HCP during his wife's cancer
investigations; describing a scenario where he would stay in the room
to reassure his wife and would break down complicated instructions
from the HCP to his spouse.30
In respect to treatment decisions, caregivers in Smyth's study
expressed the view that side effects would have an influence on the
pursuit of any hypothetical cancer treatments, with some only willing
to opt for active treatments when the side effects were less severe.26
It was noted in another study, however, that comprehensive treat-
ment information on the risks and side effects were not always fully
explained to caregivers, and often misunderstood.28 In respect to the
level of information received, some caregivers reported receiving
enough verbal information, such as leaflets, but others described feel-
ing they had to seek information for themselves postconsultation.30
Smyth's study of current practices in breast cancer treatment
found that dementia severity had an impact on the decision making
of caregivers towards screening and hypothetical treatment scenar-
ios.26 For caregivers of women with severe dementia, only comfort
care was suggested, while in women with mild‐moderate dementia,
caregivers were more likely to choose typically “aggressive” treat-
ments. It was also noted that caregiver treatment decisions, while
hypothetical, did not always take into consideration the patient's
comorbidities and life expectancy.26
Courtier and colleagues highlighted that people with dementia are
likely to receive less treatment than patients without dementia.27 Rea-
sons for this include the implications of dementia on life expectancy
and the inability to tolerate treatments with complex regimens and
severe side effects.27 McWilliams and colleagues also noted that the
combination of cognition and communication impairments had a direct
influence on treatment options, particularly the potential for sideeffects,28 and the impact on quality of life for the person living with
dementia was noted in another study.30
The impact of dementia on treatment was not always considered
by HCPs, and there was little regard for how treatment pathways
could be adapted to meet the patient's needs.29 In this context,
Witham and associates posit that the adaption of treatment regimens
is needed for this population.29 When discussing treatment options
with the HCP, caregivers reported unmet information needs; whereby
information was not always communicated in an appropriate format,
nor adapted in a way that was specific to patients with a cancer‐
dementia diagnosis.28
3.2.3 | The role of the caregiver and the
caregiver‐patient relationship
The caregiver plays an important role in cancer treatment decision
making, mainly by facilitating discussion around the treatment and
care preferences of people who lack capacity. All six studies recruited
caregivers.25-30
In the study led by McWilliams and colleagues, caregivers played a
role in both uncovering symptoms and seeking help for the person
with dementia, describing these as “detective stories.”30 In other stud-
ies, family and informal caregivers were described as the key to a suc-
cessful consultation27,28 and best placed to represent the voice of the
patient; particularly in scenarios where the caregiver knew the patient
well.27 This point was also echoed in McWilliams and colleagues'
study, whereby the researcher reflected on the significance of the
“longitudinal and biographical” knowledge of the caregiver in research
interviews.30 In some cases however, Witham and colleagues noted
that patients were prone to downplaying the importance of the care-
giver role and that this in turn meant that advocating on behalf of the
patient could be challenging for their relatives.29
Caregivers are often relied upon to ensure that patients adhere
safely to treatment and monitor any untoward side effects.27 New
treatment regimens, additional appointments, and assisted home
care needs may increase the demand on caregivers themselves, such
as radiotherapy treatment, which may require repeated trips to hos-
pital.30 These additional burdens on the caregiver were not always
considered during treatment discussions,28 and HCPs were not
always found to enquire about the needs of the caregiver.27 As a
result, some caregivers reported feeling excluded from the patient's
cancer journey.29 Caregivers in the same study felt that their role
was often marginalized by the HCP; describing a scenario where
their knowledge and judgment of the person with dementia was
questioned by the HCP.29
It is posited that the caregiver‐patient relationship itself may have
a direct impact on the outcome of treatment decisions. Courtier and
colleagues noted that in scenarios where the caregiver did not know
the patient personally, “memory loss acted as a barrier to a successful
consultation.”27 The HCPs' reliance on informal and family caregivers
was also highlighted by McWilliams and colleagues, who reported dif-
ficulties where patients with dementia had attended clinic with a care-
giver who had limited knowledge and no relationship to the patient.28
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sions on their behalf. The HCPs in courtier's paper were happy to con-
duct consultations with the caregiver taking the lead decision‐making
role; however, this could sometimes have the unintended effect of dis-
guising memory difficulties experienced by the person with dementia,
unless it was disclosed or made known to the clinician.27 However,
Harrison Dening and colleagues reported that the dependency on
caregivers to interpret patient decisions might be misplaced. In their
study of hypothetical treatment scenarios, caregivers and patients
did not always agree consistently on future treatment scenarios.
Where asked about advanced cancer treatment scenarios, patients
with dementia had a preference for antibiotic treatment (47%) over
CPR (30%) and tube feeding (37%). Within dyads, there was a low
level of agreement.254 | DISCUSSION
The key findings from this review highlight the lack of dementia spe-
cific support at the start of the cancer journey. People with dementia
require additional support, and time for discussion, when planning
treatment and attending appointments. While caregivers are often
relied upon for their biographical knowledge, their support and infor-
mation needs are not always considered by HCPs. These findings
show that there is a missed opportunity for allowing caregivers a more
active role in consultations and treatment decision making for people
with dementia and cancer.
The main aim of this review was to explore how caregivers are
involved in making treatment decisions for older people living demen-
tia who receive a new diagnosis of cancer. This aim, however, was
only partially achieved. One reason for this was the limited scope of
studies that have focused specifically on caregiving for this subpopula-
tion. The intention was to review studies that explored treatment
decision making in the context of early stage cancer, with a focus on
life‐sustaining treatment, rather than end of life treatment decision
making. However, very few studies could be found in the initial scop-
ing stages of the review.
Although the search strategy focused on studies that recruited
caregivers, one theme emerging from this review is the notion that
discussions around memory, behavioral and psychological symptoms
(BPSD) of dementia are absent from the cancer consultation. It is
therefore unclear if these symptoms are taken into account when
discussing the suitability of different treatments. The studies included
in this review have highlighted some of the barriers to navigating
health care appointments and treatment discussions. These issues
are consistent with the wider literature, which highlights the complex-
ities involved with HCP encounters for people with dementia.31
While some of the studies included in this review have explored
the impact of dementia on treatment decision making, there has been
insufficient focus on how caregivers make treatment decisions, the
type of information that caregivers would prefer to receive, and how
advance decisions are used in the decision‐making discussions. Only
one study made reference to the theme of maintaining the “pre‐dementia” preferences of people with dementia in respect to breast
screening; however, these preferences were not upheld as the sever-
ity of dementia increased.26
A significant finding from the literature was the lack of knowledge
and dementia awareness among health care professionals. There may
be other complex issues influencing the treatment decision that have
not been fully addressed. This may include the age, frailty, mobility,
and independence of the person with dementia.4.1 | Study limitations
The small number of studies in this review highlights the need for
more research in to the cancer treatment decision‐making experiences
of older people with dementia and their caregivers. One explanation
for the lack of studies in this area may be that this population is diffi-
cult to access and obtain consent to participate in research studies.
The settings for the studies included were cancer clinics,27-30 demen-
tia registries,26 and memory clinics,25 which are key settings for cap-
turing patients with dementia or their caregivers. Despite this,
recruitment was still challenging. Two studies reflected on the chal-
lenges in identifying participants, the consent process and small num-
ber of eligible participants.25,27 Courtier and colleagues reflected on
how their study sample was smaller than expected,27 hinting at under-
lying inequality in access to cancer services in those with a dementia
diagnosis.
Of the studies included in this review, the level of cognitive impair-
ment (mild/moderate/severe) and functioning of patients was not
always clear, except in the two studies, which reported dementia sub-
types.29,30 It is therefore not possible to make generalizations regard-
ing all older patients with dementia. It is not possible to make any
assumptions about the experiences of caregivers for people with mild
dementia verses severe dementia, and more research is needed to
translate findings to a range of cancer populations.274.2 | Clinical implications
The involvement of people living with dementia in research requires a
high level of ethical scrutiny. In addition, there are strict safeguarding
policies in place for any research involving participants with limited
cognitive capacity. The small numbers of participants included in these
papers hint at the complexities involved in recruitment and the addi-
tional support that caregivers and patients in this population may need
to participate in research.
Low recruitment may also be linked to the sensitive nature of mak-
ing decisions for another person, at what is undoubtedly a highly emo-
tive time in their cancer journey. Receiving a cancer diagnosis can be
psychologically stressful for both people with dementia and their care-
givers. Therefore, deciding on the right time to approach caregivers
might affect their willingness to take part in research. For this reason,
many researchers may be cautious about causing distress, and care-
givers may gate‐keep access to people with dementia.32
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ground context of dementia‐cancer research. This review has identi-
fied a clear need to increase specialist dementia support for both the
patient and caregivers from the initial consultation and throughout
the cancer care pathway. Ensuring that HCPs have appropriate train-
ing and can identify memory, behavioral and cognition problems will
mean that any advice or treatment recommended is tailored appropri-
ately to the patient. More specific information tailored towards care-
givers and people living with dementia is also needed in order to
optimize treatment decision making.5 | CONCLUSION
Cancer treatment decision making for older people with dementia
remains a complex issue. With an ever‐increasing aged population, this
research raises concerns about the management of people with cancer
who lack mental capacity and the support needs for those who are
directly involved in making difficult choices on behalf of the people
they care for. Further exploration of caregiver experiences in this con-
text is needed.
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